Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Klamová

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Vnitrni Lekarstvi|August 6, 2013
[Tyrosine kinase inhibitors -  major change in the prognosis of chronic myeloid leukaemia]H Klamová
Casopis Lekaru Ceskych|August 30, 1985
[Nitrosamines--potential carcinogens?]H Klamová, M Fucík
Casopis Lekaru Ceskych|April 17, 1996
[Photobiologic effects of porphyrins and their use in therapy of tumors]Z Hrkal, H Klamová
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1990
Inhibitor of granulopoiesis in human cyclic neutropeniaV Cukrová, H Klamová
Casopis Lekaru Ceskych|November 10, 2004
[Imatinib--a new perspective in the treatment of tumors]P Klener, H Klamová
Physiological Research|June 11, 2019
To the approximate size of the nuclear region occupied by nucleolar bodies during cell differentiation and maturation using the human leukemic granulocytic lineage as a convenient modelK Smetana, H Klamová, D Mikulenková
Neoplasma|February 9, 2000
A note on nucleoli in granulocytic precursors of the granulopoietic proliferating compartment in patients suffering from the chronic phase of chronic myeloid leukemia treated with two different drugs with different mode of actionK Smetana, I Jirásková, H Klamová
Folia Biologica|March 24, 2005
Nucleoli in human early erythroblasts (K2, K1, K1/2 cells)K Smetana, I Jirásková, H Klamová
Folia Biologica|October 18, 2020
Dominant Nucleolus in the Progenitor Cell Using Human Bone Marrow Erythroid and Granulocytic Cell Lineages as a Model. A Morphological and Cytochemical NoteK Smetana, H Klamová, D Mikulenková
Casopis Lekaru Ceskych|February 24, 2001
[Gene expression in white blood cells in chronic myeloid leukemia]H Bruchová, H Klamová, R Brdicka
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Vnitrni Lekarstvi|August 6, 2013
[Tyrosine kinase inhibitors -  major change in the prognosis of chronic myeloid leukaemia]H Klamová
Casopis Lekaru Ceskych|August 30, 1985
[Nitrosamines--potential carcinogens?]H Klamová, M Fucík
Casopis Lekaru Ceskych|April 17, 1996
[Photobiologic effects of porphyrins and their use in therapy of tumors]Z Hrkal, H Klamová
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1990
Inhibitor of granulopoiesis in human cyclic neutropeniaV Cukrová, H Klamová
Casopis Lekaru Ceskych|November 10, 2004
[Imatinib--a new perspective in the treatment of tumors]P Klener, H Klamová
Physiological Research|June 11, 2019
To the approximate size of the nuclear region occupied by nucleolar bodies during cell differentiation and maturation using the human leukemic granulocytic lineage as a convenient modelK Smetana, H Klamová, D Mikulenková
Neoplasma|February 9, 2000
A note on nucleoli in granulocytic precursors of the granulopoietic proliferating compartment in patients suffering from the chronic phase of chronic myeloid leukemia treated with two different drugs with different mode of actionK Smetana, I Jirásková, H Klamová
Folia Biologica|March 24, 2005
Nucleoli in human early erythroblasts (K2, K1, K1/2 cells)K Smetana, I Jirásková, H Klamová
Folia Biologica|October 18, 2020
Dominant Nucleolus in the Progenitor Cell Using Human Bone Marrow Erythroid and Granulocytic Cell Lineages as a Model. A Morphological and Cytochemical NoteK Smetana, H Klamová, D Mikulenková
Casopis Lekaru Ceskych|February 24, 2001
[Gene expression in white blood cells in chronic myeloid leukemia]H Bruchová, H Klamová, R Brdicka
Pageof 4